These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 445480)

  • 1. Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.
    Jarman M; Milsted RA; Smyth JF; Kinas RW; Pankiewicz K; Stec WJ
    Cancer Res; 1979 Jul; 39(7 Pt 1):2762-7. PubMed ID: 445480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide metabolism in children.
    Yule SM; Boddy AV; Cole M; Price L; Wyllie R; Tasso MJ; Pearson AD; Idle JR
    Cancer Res; 1995 Feb; 55(4):803-9. PubMed ID: 7850793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of deuterium-labeled analogs of cyclophosphamide and its metabolites.
    Griggs LJ; Jarman M
    J Med Chem; 1975 Nov; 18(11):1102-6. PubMed ID: 1177255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLasma half-life and urinary excretion of cyclophosphamide in children.
    Sladek NE; Priest J; Doeden D; Mirocha CJ; Pathre S; Krivit W
    Cancer Treat Rep; 1980; 64(10-11):1061-6. PubMed ID: 7459891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
    Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M
    Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate.
    Hamdy DA; Brocks DR
    Chirality; 2009 Jul; 21(7):704-12. PubMed ID: 18988259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
    Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cimetidine on cyclophosphamide metabolism in rabbits.
    Anthony LB; Long QC; Struck RF; Hande KR
    Cancer Chemother Pharmacol; 1990; 27(2):125-30. PubMed ID: 2249327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508.
    Chan KK; Hong PS; Tutsch K; Trump DL
    Cancer Res; 1994 Dec; 54(24):6421-9. PubMed ID: 7987837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients.
    Hadidi AH; Coulter CE; Idle JR
    Cancer Res; 1988 Sep; 48(18):5167-71. PubMed ID: 3409242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
    Hong PS; Srigritsanapol A; Chan KK
    Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypothetical metabolites of 2-bis(2-chloroethyl)amino-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide)].
    Norpoth K; Golovinsky E; Rauen HM
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):377-83. PubMed ID: 5420710
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.
    Balbinder E; Reich CI; Shugarts D; Keogh J; Fibiger R; Jones T; Banks A
    Cancer Res; 1981 Jul; 41(7):2967-72. PubMed ID: 7018675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis.
    de Miranda Silva C; Fernandes BJ; Donadi EA; Silva LM; Coelho EB; Dantas M; Marques MP; Lanchote VL
    J Clin Pharmacol; 2009 Aug; 49(8):965-72. PubMed ID: 19546252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry.
    Kasel D; Jetter A; Harlfinger S; Gebhardt W; Fuhr U
    Rapid Commun Mass Spectrom; 2004; 18(13):1472-8. PubMed ID: 15216508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetics of clausenamide enantiomers and their major metabolites after single intravenous and oral administration to rats.
    Zhu CJ; Zhang JT
    Chirality; 2003 Oct; 15(8):668-73. PubMed ID: 12923804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.
    Lim WH; Hooper WD
    Drug Metab Dispos; 1989; 17(2):212-7. PubMed ID: 2565213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
    Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
    Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective metabolism of cisapride and enantiomer-enantiomer interaction in human cytochrome P450 enzymes: major role of CYP3A.
    Desta Z; Soukhova N; Morocho AM; Flockhart DA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):508-20. PubMed ID: 11454912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.